Expression of moesin and its associated molecule CD44 in epithelial skin tumors

Journal of Cutaneous Pathology

Volumn 25, Issue 5, 1998, Pages 237-243

  Ichikawa, Takeshi ^a   Masumoto, Junya ^a   Kaneko, Miwako ^a   Saida, Toshiaki ^a   Sagara, Junji ^a   Taniguchi, Shun'ichiro ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MOESIN;

ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM TUMOR; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; METASTASIS POTENTIAL; PAGET SKIN DISEASE; SQUAMOUS CELL CARCINOMA; STAINING; STRATUM CORNEUM; VERRUCOUS CARCINOMA;

ANTIGENS, CD44; CARCINOMA; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOACANTHOMA; KERATOSIS; MICROFILAMENT PROTEINS; NEOPLASMS, GLANDULAR AND EPITHELIAL; PAGET'S DISEASE, EXTRAMAMMARY; PROTEINS; SKIN; SKIN NEOPLASMS;

EID: 0031747027     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01727.x     Document Type: Article

References (28)

1. Lankes W, Griesmacher A, Grünwald J, Schwartz-Albiez R, Keller R. A heparin-binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J 1988: 251: 831.
2. Lankes WT, Furthmayr H. Moesin: A member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 1991: 88: 8297.
3. Tsukita Sa, Oishi K, Sato N, Sagara J, Kawai A, Tsukita Sh. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994: 126: 391.
4. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990: 61: 1303.
5. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992: 89: 12160.
6. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991: 65: 13.
7. Guttinger M, Sutti F, Barnier C, Mackay C, Berti E. Expression of CD44 standard and variant forms in skin tumors loss of CD44 correlates with aggressive potential. Eur J Dermatol 1995: 5: 398.
8. Seiter S, Tilgen W, Herrmann K, et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 1996: 428: 141.
9. Prieto VG, Reed JA, McNutt NS, Bogdany JK, Lugo J, Shea CR. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol 1995: 17: 447.
10. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita Sa, Tsukita Sh. A gene family consisting of ezrin, radixin and moesin. J Cell Sci 1992: 103: 131.
11. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993: 105: 1025.
12. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993: 72: 791.
13. Yonemura S, Nagafuchi A, Sato N, Tsukita Sh. Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J Cell Biol 1993: 120: 437.
14. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 1991: 3: 347.
15. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993: 54: 271.
16. Mackay C, Terpe H, Stauder R, Marston W, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994: 124: 71.
17. Kaya G, Rodriguez I, Lorcano J, Vassalli P, Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Gene Dev 1997: 11: 996.
18. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exou v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 1993: 122: 431.
19. Seelentag WFK, Günthert LF, Saremaslani P, et al. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Int J Cancer 1996: 69: 218.
20. Baum H-P, Schmid T, Schock G, Reichrath J. Expression of CD44 isoforms in basal cell carcinomas. Br J Dermatol 1996: 134: 465.
21. Hale LP, Patel DD, Clark RE, Haynes BF. Distribution of CD44 variant isoforms in human skin: differential expression in components of benign and malignant epithelia. J Cutan Pathol 1995: 22: 536.
22. Tsuji T. Mammary and extramammary Paget's disease: expression of Ca15-3, Ka-93, Ca19-9 and CD44 in Paget cells and adjacent normal skin. Br J Dermatol 1995: 132: 7.
23. Tsukita Sa, Yonemura S, Tsukita Sh. ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem Sci 1997: 22: 53.
24. Krieg J, Hunter T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 1992: 267: 19258.
25. Groves RW, Allen MH, MacDonald DM. Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumors. J Cutan Pathol 1992: 19: 66.
26. Urushidani T, Hanzel D, Forte J. Characterization of an 80-kDa phosphoprotein involved in parietal cell stimulation. Am J Physiol 1989: 256: G1070.
27. Nakamura F, Amieva M, Furthmayr H. Phosphorylation of threonine 558 in the carboxyl-terminal actin-binding domain of moesin by thrombin activation of human platelets. J Biol Chem 1995: 270: 31377.
28. Hirao M, Sato N, Kondo T, et al. Regulation mechanism of ERM protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996: 135: 37.